200 related articles for article (PubMed ID: 20529847)
1. Role for hepatic and circulatory ST6Gal-1 sialyltransferase in regulating myelopoiesis.
Jones MB; Nasirikenari M; Feng L; Migliore MT; Choi KS; Kazim L; Lau JT
J Biol Chem; 2010 Aug; 285(32):25009-17. PubMed ID: 20529847
[TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory IgG production requires functional P1 promoter in β-galactoside α2,6-sialyltransferase 1 (ST6Gal-1) gene.
Jones MB; Nasirikenari M; Lugade AA; Thanavala Y; Lau JT
J Biol Chem; 2012 May; 287(19):15365-70. PubMed ID: 22427662
[TBL] [Abstract][Full Text] [Related]
3. Beta-galactoside alpha2,6-sialyltransferase I cleavage by BACE1 enhances the sialylation of soluble glycoproteins. A novel regulatory mechanism for alpha2,6-sialylation.
Sugimoto I; Futakawa S; Oka R; Ogawa K; Marth JD; Miyoshi E; Taniguchi N; Hashimoto Y; Kitazume S
J Biol Chem; 2007 Nov; 282(48):34896-903. PubMed ID: 17897958
[TBL] [Abstract][Full Text] [Related]
4. Remodeling of marrow hematopoietic stem and progenitor cells by non-self ST6Gal-1 sialyltransferase.
Nasirikenari M; Veillon L; Collins CC; Azadi P; Lau JTY
J Biol Chem; 2014 Mar; 289(10):7178-7189. PubMed ID: 24425878
[TBL] [Abstract][Full Text] [Related]
5. Increased alpha2,6 sialylation of N-glycans in a transgenic mouse model of hepatocellular carcinoma.
Pousset D; Piller V; Bureaud N; Monsigny M; Piller F
Cancer Res; 1997 Oct; 57(19):4249-56. PubMed ID: 9331085
[TBL] [Abstract][Full Text] [Related]
6. Biologic contribution of P1 promoter-mediated expression of ST6Gal I sialyltransferase.
Appenheimer MM; Huang RY; Chandrasekaran EV; Dalziel M; Hu YP; Soloway PD; Wuensch SA; Matta KL; Lau JT
Glycobiology; 2003 Aug; 13(8):591-600. PubMed ID: 12672700
[TBL] [Abstract][Full Text] [Related]
7. The blood-borne sialyltransferase ST6Gal-1 is a negative systemic regulator of granulopoiesis.
Dougher CWL; Buffone A; Nemeth MJ; Nasirikenari M; Irons EE; Bogner PN; Lau JTY
J Leukoc Biol; 2017 Aug; 102(2):507-516. PubMed ID: 28550122
[TBL] [Abstract][Full Text] [Related]
8. Systemic ST6Gal-1 Is a Pro-survival Factor for Murine Transitional B Cells.
Irons EE; Lau JTY
Front Immunol; 2018; 9():2150. PubMed ID: 30294329
[TBL] [Abstract][Full Text] [Related]
9. Cleavage of ST6Gal I by radiation-induced BACE1 inhibits golgi-anchored ST6Gal I-mediated sialylation of integrin β1 and migration in colon cancer cells.
Lee M; Park JJ; Ko YG; Lee YS
Radiat Oncol; 2012 Mar; 7():47. PubMed ID: 22449099
[TBL] [Abstract][Full Text] [Related]
10. Altered eosinophil profile in mice with ST6Gal-1 deficiency: an additional role for ST6Gal-1 generated by the P1 promoter in regulating allergic inflammation.
Nasirikenari M; Chandrasekaran EV; Matta KL; Segal BH; Bogner PN; Lugade AA; Thanavala Y; Lee JJ; Lau JT
J Leukoc Biol; 2010 Mar; 87(3):457-66. PubMed ID: 20007243
[TBL] [Abstract][Full Text] [Related]
11. Hepatic acute phase induction of murine beta-galactoside alpha 2,6 sialyltransferase (ST6Gal I) is IL-6 dependent and mediated by elevation of exon H-containing class of transcripts.
Dalziel M; Lemaire S; Ewing J; Kobayashi L; Lau JT
Glycobiology; 1999 Oct; 9(10):1003-8. PubMed ID: 10521536
[TBL] [Abstract][Full Text] [Related]
12. Protein sialylation by sialyltransferase involves radiation resistance.
Lee M; Lee HJ; Bae S; Lee YS
Mol Cancer Res; 2008 Aug; 6(8):1316-25. PubMed ID: 18708363
[TBL] [Abstract][Full Text] [Related]
13. Extrinsic sialylation is dynamically regulated by systemic triggers
Manhardt CT; Punch PR; Dougher CWL; Lau JTY
J Biol Chem; 2017 Aug; 292(33):13514-13520. PubMed ID: 28717006
[TBL] [Abstract][Full Text] [Related]
14. The ST6Gal I sialyltransferase selectively modifies N-glycans on CD45 to negatively regulate galectin-1-induced CD45 clustering, phosphatase modulation, and T cell death.
Amano M; Galvan M; He J; Baum LG
J Biol Chem; 2003 Feb; 278(9):7469-75. PubMed ID: 12499376
[TBL] [Abstract][Full Text] [Related]
15. ST6Gal-I regulates macrophage apoptosis via α2-6 sialylation of the TNFR1 death receptor.
Liu Z; Swindall AF; Kesterson RA; Schoeb TR; Bullard DC; Bellis SL
J Biol Chem; 2011 Nov; 286(45):39654-62. PubMed ID: 21930713
[TBL] [Abstract][Full Text] [Related]
16. Forced expression of α2,3-sialyltransferase IV rescues impaired heart development in α2,6-sialyltransferase I-deficient medaka.
Omoto T; Wu D; Maruyama E; Tajima K; Hane M; Sato C; Kitajima K
Biochem Biophys Res Commun; 2023 Mar; 649():62-70. PubMed ID: 36745971
[TBL] [Abstract][Full Text] [Related]
17. Expression of beta-galactoside alpha2,6 sialyltransferase and of alpha2,6-sialylated glycoconjugates in normal human liver, hepatocarcinoma, and cirrhosis.
Dall'Olio F; Chiricolo M; D'Errico A; Gruppioni E; Altimari A; Fiorentino M; Grigioni WF
Glycobiology; 2004 Jan; 14(1):39-49. PubMed ID: 14514712
[TBL] [Abstract][Full Text] [Related]
18. α2,6-Sialylation promotes immune escape in hepatocarcinoma cells by regulating T cell functions and CD147/MMP signaling.
Wang L; Li S; Yu X; Han Y; Wu Y; Wang S; Chen X; Zhang J; Wang S
J Physiol Biochem; 2019 Jun; 75(2):199-207. PubMed ID: 30972697
[TBL] [Abstract][Full Text] [Related]
19. In vivo cleavage of alpha2,6-sialyltransferase by Alzheimer beta-secretase.
Kitazume S; Nakagawa K; Oka R; Tachida Y; Ogawa K; Luo Y; Citron M; Shitara H; Taya C; Yonekawa H; Paulson JC; Miyoshi E; Taniguchi N; Hashimoto Y
J Biol Chem; 2005 Mar; 280(9):8589-95. PubMed ID: 15364953
[TBL] [Abstract][Full Text] [Related]
20. Sialylation of epidermal growth factor receptor regulates receptor activity and chemosensitivity to gefitinib in colon cancer cells.
Park JJ; Yi JY; Jin YB; Lee YJ; Lee JS; Lee YS; Ko YG; Lee M
Biochem Pharmacol; 2012 Apr; 83(7):849-57. PubMed ID: 22266356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
